A Study to Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary Advanced or Recurrent Endometrial Cancer

NCT07652515 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Endometrial

Interventions

DRUG: Dostarlimab
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

GlaxoSmithKline